Groupe Francophone des Myelodysplasies

OrganisationROR

Trials

  • NCT05782127

    Phase 1/2, Active, not recruiting, 36 people, 23 Mar 2023

  • NCT05768711

    Phase 2, Active, not recruiting, 44 people, 14 Mar 2023

  • NCT05226455

    Phase 1/2, Active, not recruiting, 55 people, 7 Feb 2022

  • NCT02688140

    Collaborator, Phase 3, Completed, 133 people, 23 Feb 2016

  • NCT02214407

    Phase 3, Completed, 170 people, 12 Aug 2014

  • NCT01813838

    Phase 1/2, Terminated, 5 people, 19 Mar 2013

  • NCT01718366

    Phase 1/2, Status unknown, 50 people, 31 Oct 2012

  • NCT01098084

    Phase 2, Completed, 41 people, 2 Apr 2010

  • NCT00411905

    Phase 1/2, Completed, 45 people, 15 Dec 2006

Papers